GB
GenomiCare Biotechnology provides precision cancer medicine services through genomic profiling and targeted therapy recommendations. The company addresses the challenge of ineffective cancer treatments by offering personalized treatment plans based on individual genetic mutations.
Updated 20 months ago
Funding
$30M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
TP
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- GenomiCare Biotechnology provides precision cancer medicine services through genomic profiling and targeted therapy recommendations. The company addresses the challenge of ineffective cancer treatments by offering personalized treatment plans based on individual genetic mutations.